BusinessNew Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment DecisionsBy Nasdaq OMXApr 30, 2018, 1:20 PM UTC
BusinessInterim Results from Biodesix® Study Indicate That VeriStrat Testing Impacts Treatment Decisions Across All Stages of Non-Small Cell Lung CancerBy Nasdaq OMXSep 15, 2017, 3:55 PM UTC
BusinessLung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib TherapyBy Nasdaq OMXJul 10, 2017, 5:09 PM UTC
